
Agile Therapeutics (AGRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Agile Therapeutics (AGRX) Stock
Start investing in Agile Therapeutics (AGRX)
About Agile Therapeutics (AGRX)
Market cap | $10.43M |
Today's volume | — |
Revenue (TTM) | $21.57M |
Avg. daily volume | 146.82K |
EBITDA (TTM) | -$13.15M |
Open | — |
Price / earnings ratio | -0.47x |
Today's range | — |
Debt / equity | — |
52 week range | $0.2 - $2.63 |
5 year debt / equity | 8.84x |
Beta (LTM) | 0.93x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 0.55x |
Ex-dividend date | — |
Next earnings | Aug 12, 2024 |
Dividend payable date | — |
Agile Therapeutics Stock Rating
Agile Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy AGRX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in AGRX stock
Navigate to the Explore page. Then, type AGRX into the search bar. When you see AGRX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased AGRX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Agile Therapeutics Stock Earnings
The value each AGRX share was expected to gain vs. the value that each AGRX share actually gained.
Agile Therapeutics (AGRX) reported Q1 2024 earnings per share (EPS) of -$0.63, missing estimates of -$0.51 by 23.53%. In the same quarter last year, Agile Therapeutics's earnings per share (EPS) was -$7.76. Agile Therapeutics is expected to release next earnings on 08/12/2024, with an earnings per share (EPS) estimate of $0.